Experience with degarelix in the treatment of prostate cancer
Degarelix is a gonadotrophin-releasing hormone (GnRH) antagonist for the first-line treatment of androgen-dependent advanced prostate cancer. It has a direct mechanism of action that blocks the action of GnRH on the pituitary with no initial surge in gonadotrophin or testosterone levels. Degarelix i...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publishing
2013-02-01
|
| Serier: | Therapeutic Advances in Urology |
| Online adgang: | https://doi.org/10.1177/1756287212461048 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|